Pfizer Inc.

NYSE: PFEHealthcare / Drug Manufacturers - Major / USA
42.77-0.2900-0.67%Vol 13 234 1561Y Perf 14.86%
Jul 19th, 2019 16:02
BID42.75 ASK42.95
Open43.19 Previous Close43.06
Pre-Market43.12 After-Trading42.75
 0.06 0.14%  -0.02 -0.05%
Target Price
46.13 
Analyst Rating
Moderate Buy 1.85
Potencial %
7.86 
Finscreener Ranking
★+     43.58
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★     48.03
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★+     49.41
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
★★+     45.58
Market Cap (mil)237 798 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
60.43 
Earnings Date
30th Jul 2019

Today's Price Range

42.7743.21

52wk Range

37.1246.47

5 Year PE Ratio Range

8.7033.70

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.87%
1 Month
-1.90%
3 Months
8.61%
6 Months
0.56%
1 Year
14.86%
3 Years
17.57%
5 Years
46.35%
10 Years
256.64%

Name / TickerPriceChg.Chg.%
PFE42.77-0.2900-0.67
AAPL202.59-3.0700-1.49
GOOG1 130.10-16.2300-1.42
MSFT136.620.20000.15
XOM74.990.15000.20
WFC46.030.21000.46
JNJ130.31-1.7600-1.33
FB198.36-2.4200-1.21
GE10.04-0.0200-0.20
JPM113.54-1.1300-0.99
Earnings HistoryEstimateReportedSurprise %
Q01 20190.770.8510.39
Q04 20180.630.641.59
Q03 20180.760.782.63
Q02 20180.750.818.00
Q01 20180.740.774.05
Q04 20170.560.6210.71
Q03 20170.650.673.08
Q02 20170.650.673.08
Earnings Per EndEstimateRevision %Trend
6/2019 QR0.770.00-
9/2019 QR0.67-4.29Negative
12/2019 FY2.880.70Positive
12/2020 FY2.96-1.00Negative
Next Report Date30th Jul 2019
Estimated EPS Next Report0.77
Estimates Count4
EPS Growth Next 5 Years %6.00
Volume Overview
Volume13 234 156
Shares Outstanding (in ths.)5 559 929
Trades Count47 545
Dollar Volume479 985 774
Avg. Volume23 418 814
Avg. Weekly Volume15 074 189
Avg. Monthly Volume22 072 943
Avg. Quarterly Volume21 952 174
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (50.00 %)
5 (50.00 %)
5 (55.56 %)
Moderate Buy
1 (10.00 %)
1 (10.00 %)
0 (0.00 %)
Hold
4 (40.00 %)
4 (40.00 %)
4 (44.44 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.85
Moderate Buy
1.85
Moderate Buy
1.89

Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drugs Enbrel and Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.

CEO: Albert Bourla

Teplephone: +1 212 733-2323

Address: 235 East 42nd Street, New York 10017, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

63%38%

Bearish Bullish

70%30%

Bearish Bullish

52%48%

News